(14971513), A. O., (14971516), R. C., (14971519), G. v. A., (14971522), C. R., (14971525), S. F., (14971528), W. L., . . . (14971558), M. J. (2025). Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.
Cytowanie według stylu Chicago (wyd. 17)(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.
Cytowanie według stylu MLA (wyd. 9)(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.